Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

Donato Rigante, Ida Orlando, Antonio Vitale, Giuseppe Lopalco, Claudia Fabiani, Luca Cantarini

Research output: Contribution to journalArticle

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences